The FDA has expanded the interchangeable designation for Yuflyma (adalimumab-aaty), a biosimilar to Humira, to include all presentations.

In May 2025, the FDA approved numerous biosimilars as interchangeable with Stelara® (ustekinumab) and Humira® (adalimumab), bringing the total ...

Samsung Bioepis and Organon shared that the Food and Drug Administration has designated the Hadlima (adalimumab-bwwd) high- ...

The Food and Drug Administration has designated Hadlima (adalimumab-bwwd) an interchangeable biosimilar to Humira (adalimumab).

The decision allows Yuflyma to be substituted for Humira at pharmacies without the intervention ... 40mg and 80mg solution for injection in a prefilled syringe and auto-injector pen. A biosimilar, ...

Yuflyma is an FDA-approved, high-concentration (100mg/mL) and citrate-free formulation of Humira biosimilar ... 40 mg and 80mg solution for injection in a prefilled syringe and in an autoinjector pen.

It is the ninth Humira biosimilar approved by the FDA ... 40 mg and 80 mg solution for injection in both a prefilled syringe and autoinjector pen.

Note: Optum Perks is a sister site of Healthline. Does the cost of Humira depend on the form (such as the pen or prefilled syringe)? It’s possible that the cost of Humira may vary depending on ...

The most common form is a prefilled injection device that is ready to use, so you do not need to learn how to use a syringe and needle ... compared the Tremfya pen to a placebo.

In the case of Humira, the medication can be given at home by injection, either in a self-injecting pen or with a syringe. A patient can inject themselves or have a friend or a family member help.

Prescriptions for Humira "pens," or syringes, cost the employer plans in Milliman's database $145,002 for every 1,000 enrollees, or about $145 per enrollee. That was 4.7% higher than the 2022 total.